

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to follicle-stimulating hormone (GO:0032354) | 9.70033717 |
| 2 | cellular response to antibiotic (GO:0071236) | 8.65581492 |
| 3 | cellular response to gonadotropin stimulus (GO:0071371) | 7.93614180 |
| 4 | response to insecticide (GO:0017085) | 6.65515684 |
| 5 | cellular response to toxic substance (GO:0097237) | 6.33978609 |
| 6 | estrogen biosynthetic process (GO:0006703) | 6.26889236 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 6.25321146 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.25321146 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 6.24713929 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.24713929 |
| 11 | low-density lipoprotein particle clearance (GO:0034383) | 6.12933964 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.91592762 |
| 13 | response to gonadotropin (GO:0034698) | 5.74927495 |
| 14 | * hormone biosynthetic process (GO:0042446) | 5.74301735 |
| 15 | Leydig cell differentiation (GO:0033327) | 5.67808441 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 5.57840098 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.41240284 |
| 18 | androgen biosynthetic process (GO:0006702) | 5.26261690 |
| 19 | vitamin D metabolic process (GO:0042359) | 5.22182859 |
| 20 | C21-steroid hormone biosynthetic process (GO:0006700) | 5.21005002 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.14368919 |
| 22 | ketone biosynthetic process (GO:0042181) | 5.12169079 |
| 23 | indole-containing compound catabolic process (GO:0042436) | 5.02796778 |
| 24 | indolalkylamine catabolic process (GO:0046218) | 5.02796778 |
| 25 | tryptophan catabolic process (GO:0006569) | 5.02796778 |
| 26 | glucocorticoid biosynthetic process (GO:0006704) | 4.96086847 |
| 27 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.93931993 |
| 28 | kynurenine metabolic process (GO:0070189) | 4.92572511 |
| 29 | alpha-linolenic acid metabolic process (GO:0036109) | 4.90702002 |
| 30 | cellular response to interferon-alpha (GO:0035457) | 4.88656186 |
| 31 | high-density lipoprotein particle remodeling (GO:0034375) | 4.85456226 |
| 32 | cysteine metabolic process (GO:0006534) | 4.82265684 |
| 33 | positive regulation of hormone biosynthetic process (GO:0046886) | 4.76624864 |
| 34 | tryptophan metabolic process (GO:0006568) | 4.76593746 |
| 35 | benzene-containing compound metabolic process (GO:0042537) | 4.72684873 |
| 36 | response to phenylpropanoid (GO:0080184) | 4.62570995 |
| 37 | lysine catabolic process (GO:0006554) | 4.58635707 |
| 38 | lysine metabolic process (GO:0006553) | 4.58635707 |
| 39 | regulation of cholesterol storage (GO:0010885) | 4.57624817 |
| 40 | serine family amino acid catabolic process (GO:0009071) | 4.55894669 |
| 41 | bile acid metabolic process (GO:0008206) | 4.49156544 |
| 42 | urea metabolic process (GO:0019627) | 4.47053321 |
| 43 | urea cycle (GO:0000050) | 4.47053321 |
| 44 | regulation of protein activation cascade (GO:2000257) | 4.39384918 |
| 45 | cellular response to epinephrine stimulus (GO:0071872) | 4.37161843 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.32848711 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 4.32809585 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 4.31977888 |
| 49 | protein carboxylation (GO:0018214) | 4.28882928 |
| 50 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.28882928 |
| 51 | complement activation, alternative pathway (GO:0006957) | 4.28787241 |
| 52 | adhesion of symbiont to host (GO:0044406) | 4.25370080 |
| 53 | nitrogen cycle metabolic process (GO:0071941) | 4.24428522 |
| 54 | aromatic amino acid family metabolic process (GO:0009072) | 4.24151083 |
| 55 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 4.23940818 |
| 56 | reverse cholesterol transport (GO:0043691) | 4.21836400 |
| 57 | homocysteine metabolic process (GO:0050667) | 4.20987713 |
| 58 | ethanol oxidation (GO:0006069) | 4.20797307 |
| 59 | regulation of triglyceride catabolic process (GO:0010896) | 4.20582532 |
| 60 | cellular response to growth hormone stimulus (GO:0071378) | 4.19930181 |
| 61 | regulation of complement activation (GO:0030449) | 4.16522005 |
| 62 | toxin metabolic process (GO:0009404) | 4.15103714 |
| 63 | cytokine metabolic process (GO:0042107) | 4.14057970 |
| 64 | glycine metabolic process (GO:0006544) | 4.12465200 |
| 65 | regulation of fibrinolysis (GO:0051917) | 4.10522631 |
| 66 | acylglycerol homeostasis (GO:0055090) | 4.08204766 |
| 67 | triglyceride homeostasis (GO:0070328) | 4.08204766 |
| 68 | response to vitamin E (GO:0033197) | 4.07907142 |
| 69 | plasma lipoprotein particle remodeling (GO:0034369) | 4.06740865 |
| 70 | protein-lipid complex remodeling (GO:0034368) | 4.06740865 |
| 71 | macromolecular complex remodeling (GO:0034367) | 4.06740865 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 4.04526979 |
| 73 | glucocorticoid metabolic process (GO:0008211) | 4.02469769 |
| 74 | oligosaccharide catabolic process (GO:0009313) | 3.99695898 |
| 75 | alpha-amino acid catabolic process (GO:1901606) | 3.97222166 |
| 76 | C21-steroid hormone metabolic process (GO:0008207) | 3.96643773 |
| 77 | aldehyde catabolic process (GO:0046185) | 3.88513310 |
| 78 | cellular response to cadmium ion (GO:0071276) | 3.87155680 |
| 79 | response to methylmercury (GO:0051597) | 3.87045950 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 3.86575801 |
| 81 | glycosphingolipid catabolic process (GO:0046479) | 3.85100733 |
| 82 | * steroid biosynthetic process (GO:0006694) | 3.84872471 |
| 83 | regulation of cholesterol esterification (GO:0010872) | 3.82771229 |
| 84 | response to corticosterone (GO:0051412) | 3.81601154 |
| 85 | response to epinephrine (GO:0071871) | 3.79947616 |
| 86 | cellular amino acid catabolic process (GO:0009063) | 3.77025868 |
| 87 | amyloid precursor protein catabolic process (GO:0042987) | 3.76351969 |
| 88 | tyrosine metabolic process (GO:0006570) | 3.76242194 |
| 89 | detection of molecule of bacterial origin (GO:0032490) | 3.76145161 |
| 90 | plasma lipoprotein particle clearance (GO:0034381) | 3.72646415 |
| 91 | cellular glucuronidation (GO:0052695) | 3.71735521 |
| 92 | estrogen metabolic process (GO:0008210) | 3.68810996 |
| 93 | 2-oxoglutarate metabolic process (GO:0006103) | 3.67543826 |
| 94 | progesterone metabolic process (GO:0042448) | 3.66284234 |
| 95 | intracellular lipid transport (GO:0032365) | 3.65291454 |
| 96 | epoxygenase P450 pathway (GO:0019373) | 3.64497788 |
| 97 | fatty acid beta-oxidation (GO:0006635) | 3.63134342 |
| 98 | serine family amino acid biosynthetic process (GO:0009070) | 3.62618343 |
| 99 | sterol catabolic process (GO:0016127) | 3.62600257 |
| 100 | cholesterol catabolic process (GO:0006707) | 3.62600257 |
| 101 | steroid catabolic process (GO:0006706) | 3.62316931 |
| 102 | short-chain fatty acid metabolic process (GO:0046459) | 3.62131509 |
| 103 | positive regulation of male gonad development (GO:2000020) | 3.62045879 |
| 104 | negative regulation of cholesterol transport (GO:0032375) | 3.59190264 |
| 105 | negative regulation of sterol transport (GO:0032372) | 3.59190264 |
| 106 | sterol transport (GO:0015918) | 3.56440477 |
| 107 | cholesterol transport (GO:0030301) | 3.56440477 |
| 108 | bile acid and bile salt transport (GO:0015721) | 3.56177790 |
| 109 | fatty acid oxidation (GO:0019395) | 3.54625461 |
| 110 | indolalkylamine metabolic process (GO:0006586) | 3.53657061 |
| 111 | glycolipid catabolic process (GO:0019377) | 3.53228138 |
| 112 | mating behavior (GO:0007617) | 3.51646726 |
| 113 | cholesterol efflux (GO:0033344) | 3.51582651 |
| 114 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.48110930 |
| 115 | organic acid catabolic process (GO:0016054) | 3.48047569 |
| 116 | carboxylic acid catabolic process (GO:0046395) | 3.48047569 |
| 117 | ketone body metabolic process (GO:1902224) | 3.47699859 |
| 118 | coenzyme catabolic process (GO:0009109) | 3.47660370 |
| 119 | positive regulation of hormone metabolic process (GO:0032352) | 3.47241579 |
| 120 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.46566842 |
| 121 | lipid oxidation (GO:0034440) | 3.46482447 |
| 122 | fatty acid catabolic process (GO:0009062) | 3.45455130 |
| 123 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 3.45026140 |
| 124 | cellular ketone metabolic process (GO:0042180) | 3.44959618 |
| 125 | cellular biogenic amine catabolic process (GO:0042402) | 3.42659470 |
| 126 | amine catabolic process (GO:0009310) | 3.42659470 |
| 127 | response to leptin (GO:0044321) | 3.42453336 |
| 128 | ovulation (GO:0030728) | 3.42157590 |
| 129 | phospholipid efflux (GO:0033700) | 3.41607667 |
| 130 | response to nitrosative stress (GO:0051409) | 3.41482625 |
| 131 | valine metabolic process (GO:0006573) | 3.41217885 |
| 132 | monocarboxylic acid catabolic process (GO:0072329) | 3.40630153 |
| 133 | * sterol metabolic process (GO:0016125) | 3.39425963 |
| 134 | uronic acid metabolic process (GO:0006063) | 3.38693668 |
| 135 | glucuronate metabolic process (GO:0019585) | 3.38693668 |
| 136 | carnitine metabolic process (GO:0009437) | 3.38661993 |
| 137 | cellular modified amino acid catabolic process (GO:0042219) | 3.38027568 |
| 138 | phagocytosis, recognition (GO:0006910) | 3.37463079 |
| 139 | regulation of cholesterol metabolic process (GO:0090181) | 3.36943696 |
| 140 | cholesterol homeostasis (GO:0042632) | 3.36640132 |
| 141 | androgen metabolic process (GO:0008209) | 3.34866508 |
| 142 | imidazole-containing compound metabolic process (GO:0052803) | 3.33808558 |
| 143 | aspartate family amino acid catabolic process (GO:0009068) | 3.33454392 |
| 144 | plasma lipoprotein particle assembly (GO:0034377) | 3.32422894 |
| 145 | sterol homeostasis (GO:0055092) | 3.32085567 |
| 146 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.31971271 |
| 147 | response to lead ion (GO:0010288) | 3.28964519 |
| 148 | positive regulation of steroid biosynthetic process (GO:0010893) | 3.24362723 |
| 149 | ceramide catabolic process (GO:0046514) | 3.24263733 |
| 150 | parturition (GO:0007567) | 3.22344835 |
| 151 | response to cadmium ion (GO:0046686) | 3.16336717 |
| 152 | cellular response to dexamethasone stimulus (GO:0071549) | 3.13557991 |
| 153 | regulation of male gonad development (GO:2000018) | 3.05880114 |
| 154 | cellular hormone metabolic process (GO:0034754) | 3.01631979 |
| 155 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.97180466 |
| 156 | response to antibiotic (GO:0046677) | 2.97000430 |
| 157 | positive regulation of monooxygenase activity (GO:0032770) | 2.96298226 |
| 158 | response to lipoprotein particle (GO:0055094) | 2.94111956 |
| 159 | response to dexamethasone (GO:0071548) | 2.90539164 |
| 160 | regulation of steroid biosynthetic process (GO:0050810) | 2.90250433 |
| 161 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.87042691 |
| 162 | response to mineralocorticoid (GO:0051385) | 2.85358114 |
| 163 | * cholesterol metabolic process (GO:0008203) | 2.79685360 |
| 164 | positive regulation of steroid metabolic process (GO:0045940) | 2.77431810 |
| 165 | L-ascorbic acid metabolic process (GO:0019852) | 2.71875265 |
| 166 | regulation of gonadotropin secretion (GO:0032276) | 2.68454970 |
| 167 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.67709793 |
| 168 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.67709793 |
| 169 | positive regulation of lipid storage (GO:0010884) | 2.64256840 |
| 170 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.59685195 |
| 171 | cholesterol biosynthetic process (GO:0006695) | 2.55475229 |
| 172 | regulation of female gonad development (GO:2000194) | 2.54988587 |
| 173 | plasma lipoprotein particle organization (GO:0071827) | 2.54979893 |
| 174 | protein-lipid complex subunit organization (GO:0071825) | 2.51099381 |
| 175 | sulfation (GO:0051923) | 2.48351919 |
| 176 | fat-soluble vitamin metabolic process (GO:0006775) | 2.47799208 |
| 177 | negative regulation of macrophage differentiation (GO:0045650) | 2.45988718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.93474020 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.11702005 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.00730623 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.60313540 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.29852434 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.16572174 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.78154129 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.52209103 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.15183372 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.52999159 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.19862145 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.02355270 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.78753683 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.73046851 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.46518014 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.36368101 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05916568 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0493917 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.96249753 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95438137 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93600094 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.91004962 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84692834 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70111170 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.66319379 |
| 26 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.61368727 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.57079876 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.53066115 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49604822 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.46107121 |
| 31 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.45969732 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45956238 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.43702364 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.43422250 |
| 35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.43220447 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.42102670 |
| 37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.40224972 |
| 38 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.40224972 |
| 39 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.39587956 |
| 40 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.36632043 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34066197 |
| 42 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.32965477 |
| 43 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.32684335 |
| 44 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.29730894 |
| 45 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.29355921 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29284814 |
| 47 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.25220659 |
| 48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24846852 |
| 49 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23987815 |
| 50 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.22728171 |
| 51 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20994936 |
| 52 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19990832 |
| 53 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19518858 |
| 54 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.18509039 |
| 55 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.17218081 |
| 56 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15388928 |
| 57 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.15045636 |
| 58 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.13401418 |
| 59 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.12999815 |
| 60 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.12764345 |
| 61 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10752558 |
| 62 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.10743826 |
| 63 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.09038457 |
| 64 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.08694826 |
| 65 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06217106 |
| 66 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.05635423 |
| 67 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.04648216 |
| 68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04116340 |
| 69 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03301734 |
| 70 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03240861 |
| 71 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02989164 |
| 72 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.02235702 |
| 73 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.02199095 |
| 74 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01548336 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.00731236 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99545683 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97855799 |
| 78 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.97381935 |
| 79 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96607011 |
| 80 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.95115145 |
| 81 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.94809805 |
| 82 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94748051 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92581277 |
| 84 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.92362873 |
| 85 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.91212351 |
| 86 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90732713 |
| 87 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.90656083 |
| 88 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89712955 |
| 89 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.89548593 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87584866 |
| 91 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.87570913 |
| 92 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.87091242 |
| 93 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86782341 |
| 94 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.86434084 |
| 95 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85952409 |
| 96 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85733767 |
| 97 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85279371 |
| 98 | CBP_21632823_ChIP-Seq_H3396_Human | 0.85243377 |
| 99 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.84658794 |
| 100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.84130726 |
| 101 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.83641141 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83393801 |
| 103 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.83263572 |
| 104 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83240342 |
| 105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82968839 |
| 106 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.82835280 |
| 107 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.82786825 |
| 108 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82660375 |
| 109 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.82603053 |
| 110 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81811780 |
| 111 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.81278483 |
| 112 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80471221 |
| 113 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.80469820 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79587412 |
| 115 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.78881877 |
| 116 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.78508387 |
| 117 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.78407146 |
| 118 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.78385783 |
| 119 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77898147 |
| 120 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.77452708 |
| 121 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.77401867 |
| 122 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.76452150 |
| 123 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.76131962 |
| 124 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76113781 |
| 125 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71345173 |
| 126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.69331693 |
| 127 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68915380 |
| 128 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.68858584 |
| 129 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.67433419 |
| 130 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.66968767 |
| 131 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.66602170 |
| 132 | ATF3_27146783_Chip-Seq_COLON_Human | 0.65523517 |
| 133 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65171534 |
| 134 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.65049534 |
| 135 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.64640588 |
| 136 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64604915 |
| 137 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.64248731 |
| 138 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.64086710 |
| 139 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.63491390 |
| 140 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.63410164 |
| 141 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.63407305 |
| 142 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.61146050 |
| 143 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.61020983 |
| 144 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.61019142 |
| 145 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.60699925 |
| 146 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.60478413 |
| 147 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60450459 |
| 148 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60243279 |
| 149 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.59673645 |
| 150 | AR_20517297_ChIP-Seq_VCAP_Human | 0.59613717 |
| 151 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59437748 |
| 152 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.57528863 |
| 153 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.56868357 |
| 154 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.56392908 |
| 155 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.55345546 |
| 156 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.54131361 |
| 157 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.54021583 |
| 158 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.53579789 |
| 159 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53560183 |
| 160 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.53157693 |
| 161 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.53076792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.25667756 |
| 2 | MP0005360_urolithiasis | 6.68328318 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.67760351 |
| 4 | MP0005365_abnormal_bile_salt | 5.54642484 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.83414503 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.05893862 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.31755966 |
| 8 | MP0003252_abnormal_bile_duct | 3.23695895 |
| 9 | MP0003195_calcinosis | 3.14383839 |
| 10 | MP0009840_abnormal_foam_cell | 3.09219481 |
| 11 | MP0005332_abnormal_amino_acid | 2.81681657 |
| 12 | MP0008004_abnormal_stomach_pH | 2.74333580 |
| 13 | MP0008995_early_reproductive_senescence | 2.71223511 |
| 14 | MP0005083_abnormal_biliary_tract | 2.58384669 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.42878491 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.33139194 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.29823876 |
| 18 | MP0006082_CNS_inflammation | 2.19224480 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 2.12123107 |
| 20 | MP0003186_abnormal_redox_activity | 2.05869923 |
| 21 | MP0000609_abnormal_liver_physiology | 2.05435712 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.99681996 |
| 23 | MP0000647_abnormal_sebaceous_gland | 1.96810925 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.88549767 |
| 25 | MP0003941_abnormal_skin_development | 1.87922673 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.77620269 |
| 27 | MP0005379_endocrine/exocrine_gland_phen | 1.74140298 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.72187453 |
| 29 | MP0000639_abnormal_adrenal_gland | 1.67200303 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.66566798 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.66181007 |
| 32 | MP0003303_peritoneal_inflammation | 1.61690587 |
| 33 | MP0005647_abnormal_sex_gland | 1.60639435 |
| 34 | MP0001764_abnormal_homeostasis | 1.57042606 |
| 35 | MP0005636_abnormal_mineral_homeostasis | 1.56177329 |
| 36 | MP0003329_amyloid_beta_deposits | 1.55609484 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.54021792 |
| 38 | MP0009697_abnormal_copulation | 1.53834767 |
| 39 | MP0000343_altered_response_to | 1.52968803 |
| 40 | MP0003950_abnormal_plasma_membrane | 1.50349118 |
| 41 | MP0003868_abnormal_feces_composition | 1.46247782 |
| 42 | MP0003315_abnormal_perineum_morphology | 1.43976110 |
| 43 | MP0003011_delayed_dark_adaptation | 1.39398063 |
| 44 | MP0009785_altered_susceptibility_to | 1.38046434 |
| 45 | MP0002090_abnormal_vision | 1.30853175 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.30109609 |
| 47 | MP0009379_abnormal_foot_pigmentation | 1.29536265 |
| 48 | MP0005451_abnormal_body_composition | 1.29478933 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 1.28207703 |
| 50 | MP0001661_extended_life_span | 1.26515085 |
| 51 | MP0005167_abnormal_blood-brain_barrier | 1.26057914 |
| 52 | MP0003786_premature_aging | 1.25905488 |
| 53 | MP0002419_abnormal_innate_immunity | 1.24383230 |
| 54 | MP0000598_abnormal_liver_morphology | 1.21309992 |
| 55 | MP0010368_abnormal_lymphatic_system | 1.17209266 |
| 56 | MP0002877_abnormal_melanocyte_morpholog | 1.16879090 |
| 57 | MP0010234_abnormal_vibrissa_follicle | 1.14828428 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.13059803 |
| 59 | MP0003690_abnormal_glial_cell | 1.12724177 |
| 60 | MP0002332_abnormal_exercise_endurance | 1.06540773 |
| 61 | MP0006054_spinal_hemorrhage | 1.05750039 |
| 62 | MP0001835_abnormal_antigen_presentation | 1.05228371 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.04836403 |
| 64 | MP0008469_abnormal_protein_level | 0.99020909 |
| 65 | MP0005220_abnormal_exocrine_pancreas | 0.98418448 |
| 66 | MP0009642_abnormal_blood_homeostasis | 0.95931942 |
| 67 | MP0001756_abnormal_urination | 0.94963142 |
| 68 | MP0001790_abnormal_immune_system | 0.93287180 |
| 69 | MP0005387_immune_system_phenotype | 0.93287180 |
| 70 | MP0003122_maternal_imprinting | 0.93079139 |
| 71 | MP0002452_abnormal_antigen_presenting | 0.92600525 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 0.91434544 |
| 73 | MP0003705_abnormal_hypodermis_morpholog | 0.90502216 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 0.90034597 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 0.89955938 |
| 76 | MP0005000_abnormal_immune_tolerance | 0.89628721 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.89417515 |
| 78 | MP0003075_altered_response_to | 0.89250520 |
| 79 | MP0004130_abnormal_muscle_cell | 0.89080902 |
| 80 | MP0005670_abnormal_white_adipose | 0.88669608 |
| 81 | MP0009763_increased_sensitivity_to | 0.88152277 |
| 82 | MP0001765_abnormal_ion_homeostasis | 0.85551223 |
| 83 | MP0005376_homeostasis/metabolism_phenot | 0.84805277 |
| 84 | MP0003718_maternal_effect | 0.81823190 |
| 85 | MP0000230_abnormal_systemic_arterial | 0.81001440 |
| 86 | MP0004510_myositis | 0.80978835 |
| 87 | MP0009384_cardiac_valve_regurgitation | 0.80518751 |
| 88 | MP0009764_decreased_sensitivity_to | 0.80497566 |
| 89 | MP0002078_abnormal_glucose_homeostasis | 0.80004877 |
| 90 | MP0005310_abnormal_salivary_gland | 0.79885966 |
| 91 | MP0005671_abnormal_response_to | 0.79877651 |
| 92 | MP0005266_abnormal_metabolism | 0.79065324 |
| 93 | MP0005164_abnormal_response_to | 0.78056133 |
| 94 | MP0005408_hypopigmentation | 0.77709388 |
| 95 | MP0001879_abnormal_lymphatic_vessel | 0.77528435 |
| 96 | MP0005025_abnormal_response_to | 0.77525154 |
| 97 | MP0002971_abnormal_brown_adipose | 0.76797714 |
| 98 | MP0002723_abnormal_immune_serum | 0.76271319 |
| 99 | MP0000013_abnormal_adipose_tissue | 0.73003230 |
| 100 | MP0005334_abnormal_fat_pad | 0.71370488 |
| 101 | MP0004947_skin_inflammation | 0.71205385 |
| 102 | MP0004043_abnormal_pH_regulation | 0.69690620 |
| 103 | MP0003959_abnormal_lean_body | 0.67738672 |
| 104 | MP0003953_abnormal_hormone_level | 0.67083983 |
| 105 | MP0005166_decreased_susceptibility_to | 0.66971705 |
| 106 | MP0009053_abnormal_anal_canal | 0.66582571 |
| 107 | MP0002160_abnormal_reproductive_system | 0.65633469 |
| 108 | MP0004782_abnormal_surfactant_physiolog | 0.65282811 |
| 109 | MP0010678_abnormal_skin_adnexa | 0.65008582 |
| 110 | MP0005253_abnormal_eye_physiology | 0.64767805 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.63929067 |
| 112 | MP0002938_white_spotting | 0.62886346 |
| 113 | MP0005666_abnormal_adipose_tissue | 0.60978884 |
| 114 | MP0005535_abnormal_body_temperature | 0.57516798 |
| 115 | MP0002876_abnormal_thyroid_physiology | 0.57396251 |
| 116 | MP0002837_dystrophic_cardiac_calcinosis | 0.57255252 |
| 117 | MP0005395_other_phenotype | 0.56875491 |
| 118 | MP0001881_abnormal_mammary_gland | 0.56873902 |
| 119 | MP0003646_muscle_fatigue | 0.56375225 |
| 120 | MP0003638_abnormal_response/metabolism_ | 0.56262002 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.55870097 |
| 122 | MP0002269_muscular_atrophy | 0.54435033 |
| 123 | MP0000604_amyloidosis | 0.52917181 |
| 124 | MP0005330_cardiomyopathy | 0.52052876 |
| 125 | MP0003724_increased_susceptibility_to | 0.48632773 |
| 126 | MP0001919_abnormal_reproductive_system | 0.47350117 |
| 127 | MP0002796_impaired_skin_barrier | 0.46251313 |
| 128 | MP0002254_reproductive_system_inflammat | 0.45529520 |
| 129 | MP0001853_heart_inflammation | 0.44701837 |
| 130 | MP0003699_abnormal_female_reproductive | 0.43991789 |
| 131 | MP0005389_reproductive_system_phenotype | 0.43760668 |
| 132 | MP0001119_abnormal_female_reproductive | 0.43752099 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.41674234 |
| 134 | MP0004147_increased_porphyrin_level | 0.41511084 |
| 135 | MP0000358_abnormal_cell_content/ | 0.41050460 |
| 136 | MP0004883_abnormal_blood_vessel | 0.41005359 |
| 137 | MP0005187_abnormal_penis_morphology | 0.40671810 |
| 138 | MP0005448_abnormal_energy_balance | 0.40553785 |
| 139 | MP0002970_abnormal_white_adipose | 0.39475243 |
| 140 | MP0004264_abnormal_extraembryonic_tissu | 0.39039038 |
| 141 | MP0008873_increased_physiological_sensi | 0.38242905 |
| 142 | MP0005058_abnormal_lysosome_morphology | 0.37549853 |
| 143 | MP0009115_abnormal_fat_cell | 0.36659685 |
| 144 | MP0001845_abnormal_inflammatory_respons | 0.36569006 |
| 145 | MP0000249_abnormal_blood_vessel | 0.35887956 |
| 146 | MP0000538_abnormal_urinary_bladder | 0.35090706 |
| 147 | MP0002135_abnormal_kidney_morphology | 0.34105772 |
| 148 | MP0005464_abnormal_platelet_physiology | 0.33114048 |
| 149 | MP0001944_abnormal_pancreas_morphology | 0.32958882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.63267394 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 6.19498081 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.19498081 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.19498081 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 5.95055733 |
| 6 | Deep venous thrombosis (HP:0002625) | 5.68148587 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.43798683 |
| 8 | Xanthomatosis (HP:0000991) | 5.31280170 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 5.31254110 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 5.08315669 |
| 11 | Hyperammonemia (HP:0001987) | 4.60052473 |
| 12 | Hyperglycinemia (HP:0002154) | 4.55360969 |
| 13 | Hyperglycinuria (HP:0003108) | 4.40178199 |
| 14 | Hypoglycemic coma (HP:0001325) | 4.34795400 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 4.28964382 |
| 16 | Complement deficiency (HP:0004431) | 4.22457450 |
| 17 | Ketosis (HP:0001946) | 4.17070975 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.15703270 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 4.15703270 |
| 20 | Hypolipoproteinemia (HP:0010981) | 4.07566001 |
| 21 | Decreased circulating renin level (HP:0003351) | 4.05886290 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.03755147 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.93126342 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.85558185 |
| 25 | Epidermoid cyst (HP:0200040) | 3.75148668 |
| 26 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.71651590 |
| 27 | Eczematoid dermatitis (HP:0000976) | 3.65909162 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.64083681 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.59673823 |
| 30 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.59022558 |
| 31 | Dicarboxylic aciduria (HP:0003215) | 3.59022558 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 3.57828438 |
| 33 | Fat malabsorption (HP:0002630) | 3.53245387 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 3.51367612 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 3.49274510 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.43337652 |
| 37 | Joint hemorrhage (HP:0005261) | 3.40464671 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 3.30328849 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 3.29058779 |
| 40 | Gonadal dysgenesis (HP:0000133) | 3.28957961 |
| 41 | Hypokalemic alkalosis (HP:0001949) | 3.28416915 |
| 42 | Ketoacidosis (HP:0001993) | 3.28360503 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 3.27037300 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.20686825 |
| 45 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.19546672 |
| 46 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.19546672 |
| 47 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.19546672 |
| 48 | Lethargy (HP:0001254) | 3.18629253 |
| 49 | Gonadotropin excess (HP:0000837) | 3.16438190 |
| 50 | Mucopolysacchariduria (HP:0008155) | 3.15413602 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.15413602 |
| 52 | Abnormality of complement system (HP:0005339) | 3.08640465 |
| 53 | Cerebral edema (HP:0002181) | 3.08015073 |
| 54 | Delayed CNS myelination (HP:0002188) | 3.04752730 |
| 55 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.01625082 |
| 56 | Loss of speech (HP:0002371) | 3.01047805 |
| 57 | Cerebral palsy (HP:0100021) | 2.99094434 |
| 58 | Metabolic acidosis (HP:0001942) | 2.96921927 |
| 59 | Abnormality of macrophages (HP:0004311) | 2.96677291 |
| 60 | Generalized aminoaciduria (HP:0002909) | 2.96504295 |
| 61 | Neonatal onset (HP:0003623) | 2.90942190 |
| 62 | Testicular neoplasm (HP:0010788) | 2.89127856 |
| 63 | Dysostosis multiplex (HP:0000943) | 2.88347619 |
| 64 | Large earlobe (HP:0009748) | 2.87790950 |
| 65 | Gout (HP:0001997) | 2.86175748 |
| 66 | Male pseudohermaphroditism (HP:0000037) | 2.85231930 |
| 67 | Hyperbilirubinemia (HP:0002904) | 2.82819776 |
| 68 | Clitoromegaly (HP:0000057) | 2.82723058 |
| 69 | Hypercholesterolemia (HP:0003124) | 2.79087114 |
| 70 | Renal salt wasting (HP:0000127) | 2.78638620 |
| 71 | Abnormality of nucleobase metabolism (HP:0010932) | 2.77370348 |
| 72 | Autoimmune thrombocytopenia (HP:0001973) | 2.75605691 |
| 73 | Steatorrhea (HP:0002570) | 2.75435448 |
| 74 | Secondary amenorrhea (HP:0000869) | 2.72559501 |
| 75 | Conjugated hyperbilirubinemia (HP:0002908) | 2.70335424 |
| 76 | Adrenal overactivity (HP:0002717) | 2.66380682 |
| 77 | Nausea (HP:0002018) | 2.66363885 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.65242980 |
| 79 | Sensorimotor neuropathy (HP:0007141) | 2.64730991 |
| 80 | Hepatic necrosis (HP:0002605) | 2.64098496 |
| 81 | Abnormal cartilage morphology (HP:0002763) | 2.61805798 |
| 82 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.60954696 |
| 83 | Hyperpituitarism (HP:0010514) | 2.60691057 |
| 84 | Neurofibrillary tangles (HP:0002185) | 2.52524215 |
| 85 | Abnormal spermatogenesis (HP:0008669) | 2.51095367 |
| 86 | Vomiting (HP:0002013) | 2.49706608 |
| 87 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.48811625 |
| 88 | Proximal tubulopathy (HP:0000114) | 2.45040691 |
| 89 | Accelerated skeletal maturation (HP:0005616) | 2.44110324 |
| 90 | Prolonged neonatal jaundice (HP:0006579) | 2.43204888 |
| 91 | Enlarged penis (HP:0000040) | 2.41028884 |
| 92 | Multiple enchondromatosis (HP:0005701) | 2.39766515 |
| 93 | Skin nodule (HP:0200036) | 2.38652365 |
| 94 | Spontaneous abortion (HP:0005268) | 2.37917938 |
| 95 | Hepatocellular carcinoma (HP:0001402) | 2.31864199 |
| 96 | Asymmetric septal hypertrophy (HP:0001670) | 2.31545685 |
| 97 | Abnormality of urine glucose concentration (HP:0011016) | 2.29888911 |
| 98 | Glycosuria (HP:0003076) | 2.29888911 |
| 99 | Brushfield spots (HP:0001088) | 2.29404340 |
| 100 | Premature ovarian failure (HP:0008209) | 2.25636842 |
| 101 | Hyperaldosteronism (HP:0000859) | 2.23465217 |
| 102 | Late onset (HP:0003584) | 2.23233687 |
| 103 | Increased CSF protein (HP:0002922) | 2.20401771 |
| 104 | Mediastinal lymphadenopathy (HP:0100721) | 2.20265821 |
| 105 | Acute encephalopathy (HP:0006846) | 2.19997916 |
| 106 | Increased muscle lipid content (HP:0009058) | 2.19144883 |
| 107 | Myocardial infarction (HP:0001658) | 2.18014452 |
| 108 | Hydroxyprolinuria (HP:0003080) | 2.16829483 |
| 109 | Abnormality of proline metabolism (HP:0010907) | 2.16829483 |
| 110 | Hypoglycemic seizures (HP:0002173) | 2.16723734 |
| 111 | Irritability (HP:0000737) | 2.15869300 |
| 112 | Vascular calcification (HP:0004934) | 2.15414502 |
| 113 | Female pseudohermaphroditism (HP:0010458) | 2.12997050 |
| 114 | Pancreatitis (HP:0001733) | 2.11795935 |
| 115 | Malnutrition (HP:0004395) | 2.10969276 |
| 116 | Rhabdomyolysis (HP:0003201) | 2.09464494 |
| 117 | Renal cortical cysts (HP:0000803) | 2.06714698 |
| 118 | Abnormal hemoglobin (HP:0011902) | 2.05705064 |
| 119 | Hyperuricemia (HP:0002149) | 2.02378337 |
| 120 | Increased purine levels (HP:0004368) | 2.02378337 |
| 121 | Spastic diplegia (HP:0001264) | 2.01281113 |
| 122 | Abnormal sex determination (HP:0012244) | 1.98300347 |
| 123 | Sex reversal (HP:0012245) | 1.98300347 |
| 124 | Alkalosis (HP:0001948) | 1.95699971 |
| 125 | Methylmalonic aciduria (HP:0012120) | 1.94976392 |
| 126 | Acanthocytosis (HP:0001927) | 1.94959305 |
| 127 | Joint swelling (HP:0001386) | 1.94652338 |
| 128 | Hepatosplenomegaly (HP:0001433) | 1.93649804 |
| 129 | Systemic lupus erythematosus (HP:0002725) | 1.92960780 |
| 130 | CNS demyelination (HP:0007305) | 1.92790273 |
| 131 | Azoospermia (HP:0000027) | 1.92367556 |
| 132 | Hypoplasia of the uterus (HP:0000013) | 1.91686947 |
| 133 | Gynecomastia (HP:0000771) | 1.90341140 |
| 134 | Anomalous pulmonary venous return (HP:0010772) | 1.90102390 |
| 135 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.89055806 |
| 136 | Lactic acidosis (HP:0003128) | 1.88953084 |
| 137 | Cardiovascular calcification (HP:0011915) | 1.87993665 |
| 138 | Esophageal varix (HP:0002040) | 1.87764831 |
| 139 | Disinhibition (HP:0000734) | 1.87595242 |
| 140 | Hepatocellular necrosis (HP:0001404) | 1.86834578 |
| 141 | Thrombophlebitis (HP:0004418) | 1.86779325 |
| 142 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.86664069 |
| 143 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.86664069 |
| 144 | Growth hormone excess (HP:0000845) | 1.86181096 |
| 145 | Abnormal gallbladder morphology (HP:0012437) | 1.85741476 |
| 146 | Myoglobinuria (HP:0002913) | 1.85622713 |
| 147 | Abnormality of the clitoris (HP:0000056) | 1.85469502 |
| 148 | Opisthotonus (HP:0002179) | 1.85312369 |
| 149 | Cholelithiasis (HP:0001081) | 1.83264166 |
| 150 | Abnormality of renin-angiotensin system (HP:0000847) | 1.78205000 |
| 151 | 3-Methylglutaconic aciduria (HP:0003535) | 1.74329194 |
| 152 | Recurrent bacterial skin infections (HP:0005406) | 1.73083655 |
| 153 | Neoplasm of head and neck (HP:0012288) | 1.72354613 |
| 154 | Esophageal neoplasm (HP:0100751) | 1.72354613 |
| 155 | Progressive neurologic deterioration (HP:0002344) | 1.71661037 |
| 156 | Symptomatic seizures (HP:0011145) | 1.71151306 |
| 157 | Acute necrotizing encephalopathy (HP:0006965) | 1.70067842 |
| 158 | Pulmonary fibrosis (HP:0002206) | 1.69718806 |
| 159 | Abnormality of the pulmonary veins (HP:0011718) | 1.69532423 |
| 160 | Metaphyseal dysplasia (HP:0100255) | 1.68974848 |
| 161 | Mitochondrial inheritance (HP:0001427) | 1.67848073 |
| 162 | Partial agenesis of the corpus callosum (HP:0001338) | 1.66826147 |
| 163 | Increased serum pyruvate (HP:0003542) | 1.66550520 |
| 164 | Abnormality of alanine metabolism (HP:0010916) | 1.65329996 |
| 165 | Hyperalaninemia (HP:0003348) | 1.65329996 |
| 166 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.65329996 |
| 167 | Tongue fasciculations (HP:0001308) | 1.65263220 |
| 168 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.65045097 |
| 169 | Increased intramyocellular lipid droplets (HP:0012240) | 1.64947825 |
| 170 | Respiratory failure (HP:0002878) | 1.64534210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.92837555 |
| 2 | ERN1 | 4.28137178 |
| 3 | FGFR4 | 2.81159496 |
| 4 | TRIB3 | 2.73197292 |
| 5 | NME2 | 2.63215539 |
| 6 | MST4 | 2.49219977 |
| 7 | PKN2 | 2.41460432 |
| 8 | TAOK3 | 2.38020615 |
| 9 | FLT3 | 2.30130206 |
| 10 | GRK7 | 2.28588155 |
| 11 | SIK1 | 2.27794533 |
| 12 | PIK3CG | 2.15751072 |
| 13 | MAP3K14 | 2.11736715 |
| 14 | KDR | 2.02303070 |
| 15 | NEK9 | 2.01416312 |
| 16 | MAP3K12 | 1.91024615 |
| 17 | PDK4 | 1.89428674 |
| 18 | PDK3 | 1.89428674 |
| 19 | BMPR2 | 1.85725120 |
| 20 | MST1R | 1.84164194 |
| 21 | TXK | 1.75237019 |
| 22 | PINK1 | 1.74701794 |
| 23 | TAOK2 | 1.71172700 |
| 24 | MAPK11 | 1.65078252 |
| 25 | ABL2 | 1.58412283 |
| 26 | STK10 | 1.55451159 |
| 27 | ERBB4 | 1.52591205 |
| 28 | STK16 | 1.49446344 |
| 29 | EIF2AK1 | 1.48821473 |
| 30 | MAP3K11 | 1.46078830 |
| 31 | BLK | 1.43715331 |
| 32 | MAP3K3 | 1.42713756 |
| 33 | INSRR | 1.42634681 |
| 34 | JAK1 | 1.39181846 |
| 35 | ADRBK2 | 1.38952187 |
| 36 | PBK | 1.38743565 |
| 37 | PDK2 | 1.37193064 |
| 38 | IKBKB | 1.37190400 |
| 39 | CAMKK2 | 1.32793101 |
| 40 | AKT3 | 1.28083270 |
| 41 | IRAK3 | 1.27240439 |
| 42 | STK38L | 1.25930235 |
| 43 | BMPR1B | 1.24966055 |
| 44 | TYK2 | 1.16638111 |
| 45 | TESK1 | 1.16112743 |
| 46 | TBK1 | 1.15348943 |
| 47 | MOS | 1.13931158 |
| 48 | AKT2 | 1.11714291 |
| 49 | PIM2 | 1.10659703 |
| 50 | PTK6 | 1.09794497 |
| 51 | MYLK | 1.09200761 |
| 52 | WEE1 | 1.09166664 |
| 53 | ERBB3 | 1.08573331 |
| 54 | CSNK1G3 | 1.05863223 |
| 55 | ACVR1B | 1.00514186 |
| 56 | TIE1 | 0.99654183 |
| 57 | LIMK1 | 0.98511371 |
| 58 | MAP2K3 | 0.97921927 |
| 59 | FER | 0.95378406 |
| 60 | DDR2 | 0.95303274 |
| 61 | CSNK1G2 | 0.95155680 |
| 62 | EPHA2 | 0.93184881 |
| 63 | TGFBR2 | 0.92161728 |
| 64 | CSNK1A1L | 0.90140477 |
| 65 | CDK7 | 0.89546811 |
| 66 | LATS1 | 0.89375116 |
| 67 | MAPK15 | 0.87805912 |
| 68 | MATK | 0.86342624 |
| 69 | MAP4K2 | 0.85576950 |
| 70 | RPS6KA5 | 0.85375831 |
| 71 | MAP2K2 | 0.85024504 |
| 72 | BUB1 | 0.84897389 |
| 73 | BRAF | 0.83588031 |
| 74 | GRK5 | 0.83185773 |
| 75 | LRRK2 | 0.81821071 |
| 76 | DYRK1B | 0.80737936 |
| 77 | TESK2 | 0.80435288 |
| 78 | MAP3K1 | 0.80348890 |
| 79 | PRKAA2 | 0.80292111 |
| 80 | IKBKE | 0.79966015 |
| 81 | MAPKAPK3 | 0.79579532 |
| 82 | PRPF4B | 0.77247702 |
| 83 | JAK2 | 0.76507508 |
| 84 | FRK | 0.75969021 |
| 85 | MAP2K6 | 0.74212736 |
| 86 | PIM1 | 0.71753935 |
| 87 | NEK1 | 0.71731988 |
| 88 | DYRK3 | 0.70035022 |
| 89 | EIF2AK3 | 0.69113785 |
| 90 | RPS6KA4 | 0.68775261 |
| 91 | ICK | 0.67049170 |
| 92 | MAP3K7 | 0.63449003 |
| 93 | ZAK | 0.63260009 |
| 94 | TLK1 | 0.63149155 |
| 95 | CAMK2G | 0.58254094 |
| 96 | MAPK4 | 0.57900588 |
| 97 | RPS6KB2 | 0.57554988 |
| 98 | ZAP70 | 0.55072188 |
| 99 | PLK4 | 0.54606887 |
| 100 | TRPM7 | 0.54273367 |
| 101 | CDK4 | 0.53819361 |
| 102 | WNK4 | 0.53800002 |
| 103 | CHUK | 0.53660274 |
| 104 | MET | 0.51358730 |
| 105 | PDK1 | 0.50908328 |
| 106 | NUAK1 | 0.50646237 |
| 107 | PIK3CA | 0.50332245 |
| 108 | PRKAA1 | 0.49745782 |
| 109 | NLK | 0.48207163 |
| 110 | MELK | 0.48205676 |
| 111 | PRKACG | 0.47667585 |
| 112 | IGF1R | 0.46720643 |
| 113 | CDK6 | 0.46492780 |
| 114 | MKNK2 | 0.46365906 |
| 115 | BRSK2 | 0.45793185 |
| 116 | RIPK1 | 0.43952071 |
| 117 | MKNK1 | 0.43755840 |
| 118 | LYN | 0.43475458 |
| 119 | ILK | 0.43349791 |
| 120 | EPHA3 | 0.42795588 |
| 121 | MAPK12 | 0.42506985 |
| 122 | ABL1 | 0.42347294 |
| 123 | ARAF | 0.41897001 |
| 124 | MAP3K6 | 0.41750978 |
| 125 | SCYL2 | 0.41068192 |
| 126 | EPHB2 | 0.41011802 |
| 127 | PRKG2 | 0.40526408 |
| 128 | MAP2K4 | 0.40432455 |
| 129 | GSK3A | 0.39891013 |
| 130 | NEK2 | 0.39597717 |
| 131 | PRKCQ | 0.38971814 |
| 132 | ERBB2 | 0.38616782 |
| 133 | MAP3K8 | 0.38198423 |
| 134 | CSF1R | 0.37955935 |
| 135 | CCNB1 | 0.36983280 |
| 136 | CAMK2D | 0.36962601 |
| 137 | MAP3K5 | 0.36648572 |
| 138 | LMTK2 | 0.36521201 |
| 139 | CSNK1A1 | 0.35939185 |
| 140 | CSNK1G1 | 0.34951697 |
| 141 | MAP2K1 | 0.34064619 |
| 142 | EGFR | 0.33909798 |
| 143 | IRAK4 | 0.33729582 |
| 144 | MAPK7 | 0.33105224 |
| 145 | TEC | 0.31933589 |
| 146 | CSK | 0.30688486 |
| 147 | MAP3K10 | 0.30034514 |
| 148 | PRKCZ | 0.29775059 |
| 149 | PDPK1 | 0.29588369 |
| 150 | CSNK2A1 | 0.29274758 |
| 151 | MAPK3 | 0.28959644 |
| 152 | IRAK1 | 0.28198778 |
| 153 | OBSCN | 0.27284690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.73017404 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10722609 |
| 3 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.90720988 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.79635494 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.78096324 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.63325577 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.62061434 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.51310796 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.42324549 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.38749182 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.35936450 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34149163 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.31456649 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.30148797 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 2.29926016 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.16560047 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.12246973 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.04116811 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01215151 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00166980 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.99498814 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.98557846 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87422642 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86320723 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84224643 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.80045394 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.72860175 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69538029 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69171471 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68379075 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.68096815 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.66868775 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.63679105 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60237990 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.58777162 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.58644516 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.57343560 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.52246817 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.47536808 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.45840350 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43488488 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.43487697 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.41888056 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.36097286 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.35359356 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33333830 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30888249 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26675388 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25614652 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.19035358 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18065814 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17886542 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17537962 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13635496 |
| 55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.11622250 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.09902873 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08478810 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07761784 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06026883 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.05901788 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.05870789 |
| 62 | Asthma_Homo sapiens_hsa05310 | 1.03199227 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94624414 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.93474194 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91337918 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90719397 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89997631 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88743925 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87662284 |
| 70 | Legionellosis_Homo sapiens_hsa05134 | 0.86028058 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.83493254 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.82914522 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.81144550 |
| 74 | Allograft rejection_Homo sapiens_hsa05330 | 0.80998861 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.79972924 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78926403 |
| 77 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.75644209 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74098765 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73147625 |
| 80 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72503682 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72285822 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69603127 |
| 83 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68697379 |
| 84 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64241723 |
| 85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.62628552 |
| 86 | Tuberculosis_Homo sapiens_hsa05152 | 0.62519836 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59240890 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58501971 |
| 89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58408813 |
| 90 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57714076 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57711842 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.57286062 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.56830434 |
| 94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56704783 |
| 95 | Ribosome_Homo sapiens_hsa03010 | 0.56012702 |
| 96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54320614 |
| 97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51794625 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50593633 |
| 99 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.49658063 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47643282 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47547698 |
| 102 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.46556216 |
| 103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45680508 |
| 104 | Parkinsons disease_Homo sapiens_hsa05012 | 0.45272243 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45195686 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44406221 |
| 107 | Salmonella infection_Homo sapiens_hsa05132 | 0.43423921 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40743684 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.37454084 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37163651 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37056537 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36789760 |
| 113 | Proteasome_Homo sapiens_hsa03050 | 0.35612758 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33463277 |
| 115 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.32867162 |
| 116 | Protein export_Homo sapiens_hsa03060 | 0.30207488 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21768331 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19272567 |
| 119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.18968882 |
| 120 | Alzheimers disease_Homo sapiens_hsa05010 | 0.17021537 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13876200 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.13097251 |
| 123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.13043782 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.12973107 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.07737109 |
| 126 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.07197324 |
| 127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.05004353 |
| 128 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.03044545 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02765658 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02116195 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00032627 |
| 132 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1310817 |
| 133 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1206548 |
| 134 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0760277 |
| 135 | RNA polymerase_Homo sapiens_hsa03020 | -0.0531008 |
| 136 | Purine metabolism_Homo sapiens_hsa00230 | -0.0299074 |

